Apple Will Sell Air Pods With Hearing Aids Built In
By Robin Foster HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- The latest AirPods from Apple will come with built-in hearing aids, the company announced Monday.
Designed as an over-the-counter hearing aid feature for those with mild to moderate hearing loss, users take hearing tests on iPhones or iPads running iOS 18, and then their AirPods make "personalized dynamic adjustments" to allow them to hear sounds that are boosted to prescribed levels in real time.
"This helps them better engage in conversation, and keeps them connected to the people and environment around them," Apple noted in a news release announcing the new product.
The hearing settings are also automatically applied to any media someone is using. The hearing test takes about five minutes. Results, including audiograms, are stored privately within the Health app, the company noted.
“Hearing health is a cornerstone of overall well-being. Protecting and preserving our hearing enhances our quality of life both in the short-term and long-term,” Rick Neitzel, a professor of environmental health sciences at the University of Michigan and lead investigator of the Apple hearing study, said in the company news release. “These tools will help people protect their ears from noise pollution, be aware of changes in their hearing over time and have important conversations with their healthcare providers when they need additional support.”
Apple noted that, according to the World Health Organization, about 1.5 billion people around the world live with hearing loss.
“For decades, Apple has led the way in designing products for everyone and supporting users with a broad spectrum of hearing abilities,” said Sarah Herrlinger, Apple’s senior director of global accessibility policy and initiatives. “These features on AirPods Pro will make an impact on so many people by driving more awareness around hearing health and empowering individuals with new customizable tools to help them stay connected.”
Along with the hearing aids, the company also announced new Apple Watch features that detect sleep apnea. Those features are expected to roll out this month after getting approval from the U.S. Food and Drug Administration, the company said.
"Every 30 days, Apple Watch will analyze breathing disturbance data and notify users if it shows consistent signs of moderate to severe sleep apnea so they can speak to their doctor about next steps, including potential diagnosis and treatment," the company explained.
“Empowering consumers everywhere to have the ability to reliably identify the presence of abnormal breathing patterns during sleep can help uncover a woefully under-diagnosed and serious medical condition such as sleep apnea,” Dr. Sairam Parthasarathy, director of the University of Arizona's Center for Sleep, Circadian and Neuroscience Research, said in the company news release. “This is a major step forward in improving public health.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-11 09:39
Read more
- Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
- Over 40? Get Fitter and Live 5 Extra Years
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
- AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
- Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
- Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions